EvoVera Moisturizing Cream
🚚 Ships same day if ordered before 2PM EST
High-potency topical peptide cream containing 1,000 mg SNAP-8® (acetyl octapeptide-3) and 200 mg GHK-Cu (copper tripeptide-1) per jar. Formulated in a moisturizing base with beeswax, royal jelly extract, and honey-derived ingredients for controlled topical application studies.
Compound Profile
Pharmaceutical Data Sheet
Mechanism of Action
How EvoVera Moisturizing Cream Works
EvoVera Moisturizing Cream combines SNAP-8® (acetyl octapeptide-3) and GHK-Cu in a moisturizing cream base. SNAP-8 is studied for its role in modulating neuromuscular junction activity in skin tissue, while GHK-Cu is investigated for extracellular matrix remodeling and collagen synthesis signaling.
- Modulates SNARE complex activity
- Studied for expression line reduction
- Acetyl octapeptide-3 analog of SNAP-25
- Activates collagen I/III synthesis genes
- Promotes extracellular matrix remodeling
- Upregulates SOD and antioxidant enzymes
SNAP-8 acts as a SNARE complex modulator, investigated for reducing the intensity of muscle contractions at the dermal level. GHK-Cu activates genes involved in collagen production, decorin synthesis, and antioxidant enzyme upregulation. Together they target both dynamic and structural aspects of skin tissue.
Based on published research on acetyl octapeptide-3 and copper tripeptide-1 mechanisms.
Preclinical Findings
Research Models
Clinical Data
Topical Peptide Delivery Research
SNAP-8 and GHK-Cu are among the most studied peptides in topical cosmeceutical research. SNAP-8 has been evaluated in multiple clinical settings for its effects on expression line depth, while GHK-Cu has extensive literature on wound healing and collagen remodeling.
Int J Cosmet Sci: Review of topical peptide efficacy in skin research models.
Published cosmeceutical peptide literature
Research Outcomes
Key Research Success Metrics
Safety Profile
Research Safety Notes
- GHK-Cu occurs naturally in mammalian plasma — well-characterized safety profile
- SNAP-8 is widely used in cosmetic peptide formulations with no significant adverse events
- Topical peptide formulations have favorable safety profiles in dermal studies
- No systemic absorption concerns at topical application concentrations
- Both peptides have extensive published safety data in cosmeceutical literature
EvoVera Moisturizing Cream is a topical peptide research formulation. For research use only. Not intended for diagnostic or therapeutic purposes.
About EvoVera Moisturizing Cream
High-potency topical peptide cream containing 1,000 mg SNAP-8® (acetyl octapeptide-3) and 200 mg GHK-Cu (copper tripeptide-1) per jar. Formulated in a moisturizing base with beeswax, royal jelly extract, and honey-derived ingredients for controlled topical application studies.
